What are the complications of coronary angiography performed via the radial approach versus the femoral approach, and what are the approximate incidence percentages for each complication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Complications of Coronary Angiography: Radial vs Femoral Access

The radial approach for coronary angiography results in significantly fewer complications than the femoral approach, with major bleeding rates of approximately 0.6-3.4% for radial versus 1.0-5.5% for femoral access, and overall vascular complications occurring in 1-2.5% of radial cases compared to 4.8-12.1% of femoral cases 1.

Major Bleeding Complications

Radial Access

  • Major bleeding: 0.6-3.4% in patients with acute coronary syndrome (ACS) 1
  • Access site bleeding: 1.2-2.6% 1
  • In STEMI patients specifically: 7.8% major bleeding 1
  • Overall bleeding complications: 1.2-16% depending on bleeding definition used 1

Femoral Access

  • Major bleeding: 1.0-5.5% in ACS patients 1
  • Access site bleeding: 3.4-6.8% 1
  • In STEMI patients: 12.2% major bleeding 1
  • When using broader ACUITY bleeding criteria: 4.5% versus 1.9% for radial 1

The number needed to treat with radial access to prevent one major bleeding event is 47 (95% CI, 35-79) 1.

Vascular Complications

Radial Access

  • Overall vascular complications: 1-2.5% 2, 3
  • Radial artery occlusion: 4-5% (similar between right and left radial) 2
  • Vasospasm: included in overall 2.5% complication rate 4
  • Pseudoaneurysm: rare 4
  • No local vascular complications reported in some series 5

Femoral Access

  • Overall vascular complications: 4.8-12.1% 3, 5
  • Large hematomas: 7.2% in STEMI patients 1
  • Pseudoaneurysm, urinary retention, hematoma: combined 9.25% 4
  • Access site complications requiring intervention: up to 23% in high-risk patients on anticoagulation 6

Key Clinical Context

In Acute Coronary Syndrome

The MATRIX trial demonstrated that radial access reduced the composite endpoint of death, MI, stroke, or major bleeding (9.8% vs 11.7%, P=0.0092), driven predominantly by lower non-CABG major bleeding (1.6% vs 2.3%) 1. This translates to 21 fewer bleeding events per 1000 ACS patients treated with radial access 1.

In STEMI Patients

The benefit of radial access is magnified in STEMI, where the STEMI-RADIAL trial showed the primary composite endpoint of major bleeding and vascular complications occurred in 1.4% with radial versus 7.2% with femoral access (P=0.0001) 1.

In Anticoagulated Patients

For patients on uninterrupted warfarin undergoing PCI, radial access demonstrated dramatically lower rates: 1% versus 23% for any vascular or bleeding complication (P=0.001), with transfusion requirements of 0% versus 15% 6.

Procedural Success and Failure Rates

Radial Access

  • Procedural success: 89-97.4% 2, 3
  • Procedural failure: 2.6-17.1% (higher in early learning curve) 3, 5
  • Selective angiography success: 93.75% 4

Femoral Access

  • Procedural success: 71-98.8% 2, 3
  • Procedural failure: 0-1.2% 3, 5
  • Selective angiography success: 85.25% 4

Important Caveats

Operator experience matters: The higher procedural failure rates with radial access (up to 17%) are seen primarily during the learning curve 5. Once operators gain experience, success rates exceed 97% 3.

Crossover complications: Patients who cross over from radial to femoral access have higher bleeding rates than those who start with femoral access, confounding some analyses 1.

Definition variability: Bleeding complication rates vary significantly based on which bleeding classification system is used (protocol-defined versus ACUITY versus BARC criteria) 1.

Mortality Impact

While not a direct complication, radial access reduces mortality in STEMI patients through reduction in bleeding complications, which are independently associated with increased short- and long-term mortality 1. Access site bleeding, though having better prognosis than non-access site bleeding, still increases mortality risk 1.

Practical Advantages of Radial Access

Beyond lower complication rates, radial access offers:

  • Shorter hospital stays: 4.06 hours versus 23.5 hours 5
  • Faster hemostasis time 4
  • Immediate patient ambulation
  • Patient preference due to comfort

The evidence strongly supports radial access as the preferred approach for coronary angiography and PCI, with the American Heart Association providing a scientific statement endorsing this approach, particularly in ACS patients 1.

Related Questions

Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
If 100 mL of normal saline is to be infused over 25 minutes and 1 mL equals 20 drops, what is the drop rate per minute?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
In a 56-year-old male with persistent testicular pain and a normal scrotal ultrasound, would a spermatic cord block be beneficial, and what outcomes and follow‑up treatment should be expected if the block improves his pain?
What does the research say about the safety and metabolic effects of short‑term (24–48 hour) fasting in healthy adults, especially according to experts who oppose fasting?
What are the indications, benefits, and guideline recommendations for thrombolysis in deep vein thrombosis (DVT)?
How is catheter-directed thrombolysis performed for acute proximal deep‑vein thrombosis in an adult patient without absolute contraindications?
Is cardiac rehabilitation still appropriate and effective 12 years after a coronary artery obstruction treated with a stent?
Do peanuts place additional strain on the kidneys, particularly in patients with chronic kidney disease?
What is the appropriate management for a patient who has wheezing, normal oxygen saturation, and visible shortness of breath while speaking and is currently receiving nebulized therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.